紫色非硫光合细菌减毒脂多糖与脂质A佐剂研究
本研究评估了源自紫色非硫光合细菌(Rhodocyclus tenuis 和 Rhodobacter sphaeroides)的减毒脂多糖(LPS)和脂质A作为佐剂的效力。以TNP-HEA为半抗原,在BALB/c雌性小鼠中比较了水包油乳剂(OIWE)配方的佐剂诱导抗TNP IgG的能力。完整LPS佐剂显著优于相应脂质A佐剂,OIWE配方优于水溶液,且抗体可维持4个月缓慢下降,R. tenuis的LPS佐剂最具前景。
要点
- 完整LPS佐剂诱导抗TNP IgG效力显著高于相应脂质A佐剂
- OIWE配方佐剂活性均高于水溶液配方
- 免疫后4个月内血清抗TNP IgG缓慢下降
核心结论
- 减毒LPS和脂质A具开发安全有效新型佐剂的潜力,R. tenuis的LPS佐剂最有前景。
研究设计与样本
- 研究从Rhodocyclus tenuis和Rhodobacter sphaeroides提取LPS并经温和酸水解分离脂质A。
- 以TNP-HEA为半抗原,在BALB/c雌性小鼠中评估OIWE配方佐剂诱导的抗TNP IgG。
- 抗TNP IgG滴度采用ELISA测定。
主要发现
- 完整LPS佐剂的OIWE配方诱导抗TNP IgG滴度显著高于相应脂质A佐剂。
- 所有LPS和脂质A佐剂的OIWE配方活性均高于水溶液配方。
- 免疫后4个月内血清抗TNP IgG水平缓慢下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adjuvants are substances that enhance adaptive immune response to antigen. Development of a safe and effective immunostimulant adjuvant is essential for the efficacy of a vaccine to protect against infectious pathogens. Purple non-sulfur photosynthetic bacteria exhibited nontoxic natural lipid A variants that are distinct in their chemical structures from that of the Escherichia coli-type lipid A. In this study, the adjuvant efficacy of attenuated lipid A variants and their corresponding lipopolysaccharides (LPSs), derived from purple photosynthetic bacteria (Rhodocyclus tenuis and Rhodobacter sphaeroides) were evaluated. LPS was extracted using modified phenol-chloroform-petroleum ether method and lipid A was separated by mild acid hydrolysis. Trinitrophenol (TNP) was conjugated to hen egg albumin (TNP-HEA) and used as haptenic antigen. The LPS and lipid A adjuvant candidates were formulated in oil-in-water emulsion (OIWE) and evaluated to elicit anti-TNP IgG against TNP-HEA conjugate in BALB/c female mice. The anti-TNP IgG titers were measured using ELISA. The intact LPS-based adjuvants present in OIWE formulation showed significantly higher efficacy to elicit anti-TNP IgG titers against TNP-HEA conjugate compared to their corresponding lipid A-based adjuvants. As expected, the OIWE formulations of all LPS- and lipid A-based adjuvant candidates showed higher activities compared to the aqueous formulations. Slow reduction in the levels of anti-TNP IgG antibodies in the serum was observed over 4 months after immunization using the LPS- and lipid A-based adjuvant candidates which may provide a long protection against pathogens. The attenuated LPSs and lipid A's from the photosynthetic bacteria showed promising results to develop novel safe and effective adjuvants that can evoke the immune response. The most promising adjuvant candidate was the LPS-based adjuvant from R. tenuis.
引用
- Masoud H. Novel adjuvants derived from attenuated lipopolysaccharides and lipid As of purple non-sulfur photosynthetic bacteria. Vaccine. 2019. PMID: 31097350. doi:10.1016/j.vaccine.2019.04.097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。